Noile-Immune Biotech Inc. (TYO:4893)

Japan flag Japan · Delayed Price · Currency is JPY
145.00
+3.00 (2.11%)
May 13, 2025, 9:42 AM JST
Market Cap 6.15B
Revenue (ttm) 7.00M
Net Income (ttm) -964.00M
Shares Out 43.30M
EPS (ttm) -22.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 49,100
Average Volume 265,740
Open 147.00
Previous Close 142.00
Day's Range 144.00 - 147.00
52-Week Range 120.00 - 353.00
Beta n/a
RSI 46.12
Earnings Date May 12, 2025

About Noile-Immune Biotech

Noile-Immune Biotech Inc. researches and develops CAR-T cells for cancer immunotherapies. The company was incorporated in 2015 and is headquartered in Minato, Japan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 25
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4893
Full Company Profile

Financial Performance

In 2024, Noile-Immune Biotech's revenue was 7.00 million, a decrease of -97.78% compared to the previous year's 316.00 million. Losses were -964.00 million, -14.69% less than in 2023.

Financial Statements

News

There is no news available yet.